(Q37399071)
Statements
A strategy for regulatory action when new adverse effects of a licensed product emerge (English)
Jeffrey K Aronson
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference